Витаминные средства

Витаминные средства
I Витами́нные сре́дства
лекарственные препараты, действующими началами которых являются витамины или их аналоги.
В медицинской практике используют В. с., содержащие один или несколько (так называемые поливитаминные препараты) витаминов. Наряду с этим широкое применение получили препараты, включающие коферментные формы некоторых витаминов (кокарбоксилаза, пиридоксальфосфат и др.). Действие В. с. прежде всего обусловлено физиологической ролью содержащихся в них витаминов как незаменимых факторов питания, в связи с чем В. с. используют в качестве профилактических и лечебных препаратов при витаминной недостаточности. Кроме того, В. с. обладают определенными фармакологическими свойствами. Так, никотиновая кислота вызывает сосудорасширяющий эффект, влияет на уровень липопротеидов в крови; пантотеновая кислота усиливает перистальтику кишечника; тиамин обладает умеренными ганглиоблокирующими свойствами и т.д. Поэтому В. с. часто применяют в комплексной терапии ряда заболеваний вместе со специфически действующими лекарственными препаратами из других групп. При этом В. с. могут усиливать терапевтическую активность таких препаратов, устранять или ослаблять побочные эффекты некоторых из них (например, антибиотиков, сульфаниламидов и др.).
Как и любые лекарственные вещества В. с. следует назначать по определенным показаниям в зависимости от их фармакотерапевтических свойств, желательно на фоне диеты, богатой белком, т.к. при этом витамины дольше удерживаются в организме. С другой стороны, витамины способствуют более полной утилизации белков. Продолжительность применения В. с. определяется характером заболевания и индивидуальной переносимостью этих препаратов. В чрезмерно больших дозах или при очень длительном применении некоторые В. с. (например, ретинол, эргокальциферол) могут вызывать острые или хронические гипервитаминозы. При появлении признаков гипервитаминозов вызвавшие их В. с. отменяют и в некоторых случаях назначают препараты, ослабляющие действие соответствующих В. с. Так, при передозировке эргокальциферола или видехола применяют ретинол, а при передозировке ретинола — аскорбиновую кислоту. Необходимо также иметь в виду, что комбинации отдельных В. с. могут быть несовместимы. Не следует вводить одновременно или смешивать в одном шприце пиридоксин и цианокобаламин, аскорбиновую кислоту и цианокобаламин, тиамин и никотиновую кислоту, тиамин с цианокобаламином и пиридоксином, т.к. при смешивании эти витамины могут разрушаться или взаимно усиливать способность друг друга вызывать аллергические реакции.
Клинико-фармакологическая характеристика основных витаминных средств приводится в таблице.
Таблица
Клинико-фармакологическая характеристика основных витаминных средств
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| Названия препаратов и | Основные свойства           | Показания к применению      | Способы применения и дозы       | Побочное и токсическое    | Форма выпуска и условия  |   |
| их синонимы                |                                          |                                             |                                                    | действие                           | хранения                             |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1                                  | 2                                       | 3                                          | 4                                                 | 5                                       | 6                                         |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Аскорбиновая            | Участвует в окислении      | Профилактика и лечение С-  | В целях профилактики                | При передозировке            | Драже и таблетки по 0,05   |   |
кислота, Acidum         | ароматических                  | гиповитаминозов,                 | авитаминоза взрослым внутрь    | возможно нарушение         г и по 0,025 г с глюкозой      |
| ascorbinicum (синоним  | аминокислот, регуляции     | геморрагические диатезы,    | (после еды) 0,05—0,1 г в день, с | функции печени и              | (для профилактических       |
| витамин С)                   | обмена коллагена,             | кровотечения, связанные с  | лечебной целью — по 0,05—0,1   | поджелудочной железы     | целей детям); таблетки по  |   |
|                                     | окислительно-                    | лучевой болезнью,               г 3—5 раз в день.                        |                                          | 0,05 г (для                           |
|                                     | восстановительных           | инфекционные болезни и      | Внутримышечно или                    |                                          | профилактических и            |
|                                     | процессов, углеводного     | интоксикации, заболевания  | внутривенно — по 1—3 мл 5%     |                                          | лечебных целей); ампулы  |    |
|                                     | обмена, свертываемости   | печени, нефропатия             | раствора в день. Детям внутрь   |                                          | по 1—2 мл 5% и 10%           |
|                                     | крови и регенерации          | беременных, аддисонова     | — по 0,05—0,1 г 2—3 раза в       |                                          | растворов (для лечебных   |   |
|                                     | тканей, стимулирует          | болезнь, вяло заживающие  | день или парентерально по 1—   |                                          | целей). Хранение: в             |
|                                     | образование стероидных   | раны, усиленное                  | 2 мл 5% раствора                       |                                          | прохладном, защищенном |    |
|                                     | гормонов, нормализует      | физическое и умственное    |                                                    |                                          | от света месте                    |
|                                     | проницаемость                  | напряжение, в период          |                                                    |                                          |                                            |
|                                     | капилляров                        | беременности и лактации     |                                                    |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Бенфотиамин,           | Синтетический аналог        | Те же, что у тиамина            | Внутрь (после еды) взрослым по | Те же, что у тиамина (см.  | Таблетки по 0,005 и 0,025    |
| Benphothiaminum          | тиамина; соответствует     |                                             | 0,025—0,05 г 1—4 раза в день.   | ниже)                                 | г. Хранение: в сухом,          |
|                                     | ему по свойствам, но        |                                             | Суточные дозы для взрослых      |                                          | защищенном от света        |   |
|                                     | превосходит по                 |                                             | 0,1—0,2 г, курс лечения — 15—  |                                          | месте                                  |
|                                     | активности                        |                                             | 30 дней. Лицам пожилого и         |                                          |                                            |
|                                     |                                          |                                             | старческого возраста — по         |                                          |                                            |
|                                     |                                          |                                             | 0,025 г 1—2 раза в день; детям   |                                          |                                            |
|                                     |                                          |                                             | от 1 года до 10 лет — по 0,01—  |                                          |                                            |
|                                     |                                          |                                             | 0,03 г в день (курс лечения 10—  |                                          |                                            |
|                                     |                                          |                                             | 20 дней), детям старше 10 лет    |                                          |                                            |
|                                     |                                          |                                             | — по 0,03—0,06 г в день (курс    |                                          |                                            |
|                                     |                                          |                                             | лечения — 15—30 дней)              |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Видехол, Videcholum  | Молекулярное соединение | Те же, что у                         | Внутрь в виде масляного            | Те же, что у                       | Масляные растворы            |
|                                     | холекальциферола            | эргокальциферола               | раствора доношенным детям по  | эргокальциферола, а         | 0,125% и 0,25% во             |   |
|                                     | (витамина D3) с                  |                                             | 30000—40000 ME в день (в 2      | также частый и жидкий      | флаконах по 5; 10 и 30        |
|                                     | холестерином. По              |                                             | приема) в течение 12—14 дней;  | стул (у детей, склонных к  мл. Хранение: список Б; в  |   |
|                                     | свойствам соответствует  |                                             | недоношенным — по 6250—        | дисфункции кишечника)     | защищенном от света        |   |
|                                     | эргокальциферолу (см.      |                                             | 10000 ME в день в течение 2      |                                          | месте при  не выше 5°       |
|                                     | ниже)                                 |                                             | мес. Для лечения рахита I           |                                          |                                            |
|                                     |                                          |                                             | степени — по 10000—15000 ME  |                                          |                                            |
|                                     |                                          |                                             | в день в 2 приема в течение 4—  |                                          |                                            |
|                                     |                                          |                                             | 6 нед.; при рахите II степени по   |                                          |                                            |
|                                     |                                          |                                             | 15000—20000 ME 2 раза в день  |                                          |                                            |
|                                     |                                          |                                             | в течение 4—6 нед.; при рахите  |                                          |                                            |
|                                     |                                          |                                             | III степени по 50000 ME в 2          |                                          |                                            |
|                                     |                                          |                                             | приема в течение 2 нед., затем   |                                          |                                            |
|                                     |                                          |                                             | по 8000 ME в течение 6 нед.,      |                                          |                                            |
|                                     |                                          |                                             | либо 800000—1200000 ME на      |                                          |                                            |
|                                     |                                          |                                             | курс лечения в течение 5—7       |                                          |                                            |
|                                     |                                          |                                             | нед.                                            |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Викасол                       | см. Кровоостанавливающие средства                                                                                                                                                                          |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Калия оротат                см. Анаболические средства                                                                                                                                                                                        |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Кальция пангамат,    | Регулирует липидный        | Комплексная терапия           | Внутрь взрослым по 0,05—0,1 г   | При значительном             | Таблетки по 0,05 г.              |
| Calcii pangamas            | обмен, улучшает               | атеросклероза, коронарной  | 3—4 раза в день. Суточные         | повышении АД препарат    | Хранение: в плотно            |   |
| (синоним: витамин В15, | усвоение кислорода           | недостаточности,                 | дозы для взрослых 0,1—0,3 г,     | назначают с                      | укупоренной таре, в           |   |
| кальгам)                       | тканями, повышает            | гепатитов, алкогольной        | для детей до 3 лет — 0,05 г, от   | осторожностью                  | сухом месте при  не          |
|                                     | содержание                       | интоксикации. Может           | 3 до 7 лет — 0,1 г, от 7 до 14      |                                          | выше 18°                             |
|                                     | креатинфосфата и             | применяться для                  | лет — 0,15 г. Курс лечения —     |                                          |                                            |
|                                     | гликогена в мышцах и        | улучшения переносимости   | 20—40 дней. Повторные курсы    |                                          |                                            |
|                                     | печени, устраняет             | сульфаниламидов и             | — через 2—3 мес.                      |                                          |                                            |
|                                     | явления гипоксии               | некоторых других                 |                                                    |                                          |                                            |
|                                     |                                          | препаратов                          |                                                    |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Кальция                      | Участвует в регуляции       | Полиневриты, невралгии,     | Внутрь взрослым по 0,1—0,2 г    | Тошнота, рвота, изжога     | Таблетки по 0,1 г; ампулы  |   |
пантотенат, Calcium   | углеводного и жирового     | парестезии, экзема,             | 2—4 раза в день; детям от 1       |                                          | по 2 мл 20% раствора.       |   |
| pantothenicum               | обмена, а также в синтезе | аллергические реакции,        | года до 3 лет — по 0,005—0,1 г   |                                          | Хранение: в сухом месте   |   |
|                                     | ацетилхолина и                  | трофические язвы, ожоги,    | на прием, от 3 до 14 лет — 0,1— |                                          |                                            |
|                                     | кортикостероидов              | токсикоз беременных,          | 0,2 г на прием 2 раза в день.       |                                          |                                            |
|                                     |                                          | бронхиты, бронхиальная      | Суточная доза для взрослых       |                                          |                                            |
|                                     |                                          | астма, недостаточность       | 0,4—0,8 г, для детей — 0,2—      |                                          |                                            |
|                                     |                                          | кровообращения.                 | 0,4 г Подкожно, внутримышечно  |                                          |                                            |
|                                     |                                          | Применяется также при        | и внутривенно взрослым вводят  |                                          |                                            |
|                                     |                                          | послеоперационной атонии   | по 1—2 мл 20% раствора, детям |                                          |                                            |
|                                     |                                          | кишечника и для                  | — в меньших дозах (в                 |                                          |                                            |
|                                     |                                          | уменьшения токсического    | соответствии с возрастом). Курс |                                          |                                            |
|                                     |                                          | действия стрептомицина      | лечения — до 3—4 мес. Местно  |                                          |                                            |
|                                     |                                          |                                             | для примочек и полосканий в      |                                          |                                            |
|                                     |                                          |                                             | виде 5% раствора 2—4 раза в     |                                          |                                            |
|                                     |                                          |                                             | день. При ожогах и вяло             |                                          |                                            |
|                                     |                                          |                                             | гранулирующих ранах                 |                                          |                                            |
|                                     |                                          |                                             | применяют также 5% мазь          |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Кверцетин,                 | Обладает свойствами        | Лечение и профилактика      | Внутрь взрослым по 0,02 г 3—5  |                                          | Таблетки по 0,02 г.              |
| Quercetinum (синоним:  | витамина Р, который         | гипо- и авитаминоза Р;         | раз в день. Курс лечения 5—6    |                                          | Хранение: в сухом,            |   |
| флавин, мелетин и       | совместно с аскорбиновой | геморрагические диатезы и  | нед.                                            |                                          | защищенном от света        |   |
| др.)                              | кислотой участвует в         | заболевания,                        |                                                    |                                          | месте                                  |
|                                     | окислительно-                    | сопровождающиеся             |                                                    |                                          |                                            |
|                                     | восстановительных           | повышением                        |                                                    |                                          |                                            |
|                                     | процессах, угнетает          | проницаемости сосудов       |                                                    |                                          |                                            |
|                                     | действие гиалуронидазы и | (ревматизм, септический      |                                                    |                                          |                                            |
|                                     | уменьшает                        | эндокардит, лучевая            |                                                    |                                          |                                            |
|                                     | проницаемость и               | болезнь, гломерулонефрит,  |                                                    |                                          |                                            |
|                                     | ломкость капилляров         | корь, скарлатина, сыпной     |                                                    |                                          |                                            |
|                                     |                                          | тиф и др.). Лечение и           |                                                    |                                          |                                            |
|                                     |                                          | профилактика поражений     |                                                    |                                          |                                            |
|                                     |                                          | капилляров некоторыми       |                                                    |                                          |                                            |
|                                     |                                          | лекарственными                   |                                                    |                                          |                                            |
|                                     |                                          | средствами                          |                                                    |                                          |                                            |
|                                     |                                          | (антикоагулянтами,              |                                                    |                                          |                                            |
|                                     |                                          | салицилатами и др.)             |                                                    |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Кислота                      | Участвует в образовании   | Профилактика и лечение      | Внутрь (после еды) для               | Могут возникать                | Таблетки по 0,05 г (для        |
никотиновая, Acidum  | ферментов,                       | пеллагры; язвенная болезнь | профилактических целей             | покраснение лица и           | лечебных целей) и ампулы |   |
| nicotinicum (синоним:    | регулирующих                   | желудка и                            | взрослым по 0,015—0,025 г,        | верхней половины             | по 1 мл 1% раствора.          |
| витамин РР, витамин   | окислительно-                    | двенадцатиперстной кишки, | детям — по 0,005—0,02 г в         | туловища,                         | Хранение: список Б; в         |
| В3, ниацин и др.)          | восстановительные           | энтероколиты, вяло              | день. При пеллагре взрослым по | головокружение, чувство   | защищенном от света        |   |
|                                     | процессы, обмен липидов  | заживающие раны и язвы,    | 0,1 г 2—4 раза в день в течение  | прилива крови к голове,     | месте                                  |
|                                     | и углеводов. Оказывает     | спазмы сосудов                   | 15—20 дней или внутримышечно | крапивница, парестезии     |                                            |
|                                     | сосудорасширяющее         | конечностей, почек и            | — по 1 мл 1% раствора 1—2       | (особенно у лиц с              |                                            |
|                                     | действие и снижает           | головного мозга,                  | раза в день в течение 10—15      | повышенной чувствитель-  |                                            |
|                                     | содержание атерогенных   | атеросклероз, острые и        | дней. Детям назначают внутрь    | ностью к препарату). При  |                                            |
|                                     | липидов в крови                | хронические гепатиты,         | по 0,005—0,05 г 2—3 раза в        | быстром внутривенном      |                                            |
|                                     |                                          | цирроз печени,                     | день. По прочим показаниям       | введении возможно           |                                            |
|                                     |                                          | инфекционные болезни        | взрослым внутрь по 0,02—0,05   | значительное понижение    |                                            |
|                                     |                                          |                                             | г (до 0,1 г), детям по 0,005—       | АД. При внутримышечном  |                                          |   |
|                                     |                                          |                                             | 0,03 г 2—3 раза в день. При        | введении вызывает           |                                            |
|                                     |                                          |                                             | ишемическом инсульте в вену    | болезненность в месте      |                                            |
|                                     |                                          |                                             | вводят 1 мл 1% раствора.           | введения                           |                                            |
|                                     |                                          |                                             | Высшие дозы для взрослых        |                                          |                                            |
|                                     |                                          |                                             | внутрь: разовая 0,1 г, суточная   |                                          |                                            |
|                                     |                                          |                                             | 0,5 г; внутривенно: разовая 0,1   |                                          |                                            |
|                                     |                                          |                                             | г, суточная 0,3 г. При хорошей    |                                          |                                            |
|                                     |                                          |                                             | переносимости суточные дозы    |                                          |                                            |
|                                     |                                          |                                             | могут быть увеличены (разовая   |                                          |                                            |
|                                     |                                          |                                             | до 0,5—1 г, суточная — до 3—5  |                                          |                                            |
|                                     |                                          |                                             | г)                                                |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Кислота фолиевая,   | Стимулирует эритропоэз   | Макроцитарные анемии и     | Внутрь взрослым с                     |                                          | Таблетки по 0,001 г            |   |
| Acidum folicuin              | (вместе с витамином В12),  | спру, анемии и лейкопении,  | профилактической целью — по   |                                          |                                            |
| (синоним витамин Вс  | участвует в обмене           | вызванные лекарственными | 0,00002—0,00005 г в день, при    |                                          |                                            |
|                                     | аминокислот, биосинтезе   | средствами, ионизирующим | беременности — по 0,0004 г в     |                                          |                                            |
|                                     | пуринов, пиримидинов и    | излучением; анемии,            | день, при кормлении грудью —   |                                          |                                            |
|                                     | нуклеиновых кислот           | возникающие после             | 0,0003 г в день. С лечебными      |                                          |                                            |
|                                     |                                          | резекции желудка и              | целями внутрь взрослым — по    |                                          |                                            |
|                                     |                                          | кишечника                            | 0,005 г в день, детям — в           |                                          |                                            |
|                                     |                                          |                                             | меньших дозах (в зависимости   |                                          |                                            |
|                                     |                                          |                                             | от возраста). Курс лечения —     |                                          |                                            |
|                                     |                                          |                                             | 20—30дней                                 |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Метилметионин-        | Оказывает липотропное и  | Язвенная болезнь желудка   | Внутрь (после еды) по 0,1 г 3—5 | Иногда возникают              | Таблетки по 0,05 г.              |
сульфония хлорид,  | детоксирующее действие, | и двенадцатиперстной          | раз в день. Курс лечения 30—40 | тошнота, рвота, усиление  | Хранение: в сухом,            |   |
| Methyli nethioninsulfonii | способствует регенерации | кишки, хронический гастрит  | дней                                           | болей, что требует             | защищенном от света        |   |
| hloridum (синоним         | повреждений слизистой     |                                             |                                                    | уменьшения дозы или        | месте, при комнатной          |
| витамин U)                   | оболочки желудочно-         |                                             |                                                    | отмены препарата             | температуре                        |
|                                     | кишечного тракта               |                                             |                                                    |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Никотинамид,            | По химическому строению | Те же, что и у кислоты         | С профилактической целью         |                                          | Таблетки по 0,015 г (для      |
| Nicotinamilum               | и действию близок к          | никотиновой, за                    | внутрь взрослым по 0,015—        |                                          | профилактических целей)    |
| (синоним: никовит и      | никотиновой кислоте и       | исключением применения в  | 0,025 г, детям — по 0,005—0,01  |                                          | и по 0,005 и 0,025 г (для      |
| др.)                              | подобно ей                        | качестве                              г 1—2 раза в день. При пеллагре |                                          | лечебных целей); ампулы  |    |
|                                     | рассматривается как         | сосудорасширяющего          | взрослым внутрь по 0,05—0,1 г   |                                          | по 1 мл 1% раствора и 1 и |    |
|                                     | витамин РР. В отличие от  | средства                              | 3—4 раза в день, детям — по     |                                          | 2 мл 2,5% раствора.            |
|                                     | никотиновой кислоты не     |                                             | 0,01—0,05 г 2—3 раза в день в   |                                          | Хранение: список Б; в         |
|                                     | оказывает заметного         |                                             | течение 15—20 дней, при других |                                          | защищенном от света        |   |
|                                     | сосудорасширяющего       |                                             | заболеваниях — по 0,02—0,05 г  |                                          | месте                                  |
|                                     | действия                           |                                             | взрослым и 0,005—0,01 г детям  |                                          |                                            |
|                                     |                                          |                                             | 2—3 раза в день. Внутривенно,   |                                          |                                            |
|                                     |                                          |                                             | внутримышечно и подкожно        |                                          |                                            |
|                                     |                                          |                                             | вводят 1—2 мл 1%, 2,5% или      |                                          |                                            |
|                                     |                                          |                                             | 5% раствора 1—2 раза в день     |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Оксикобаламин,        | Является метаболитом      | Те же, что и у                      | Внутримышечно или подкожно    | Возможны аллергические  | Ампулы по 1 мл 0,01%;        |
| Oxycobalaminum           | цианокобаламина;              | цианокобаламина                 | при анемиях — по 0,0001 г в       | реакции                             | 0,05% и 0,1% раствора.       |
|                                     | соответствует ему по        |                                             | день или через день в течение    |                                          | Хранение: в защищенном    |
|                                     | свойствам, но быстрее      |                                             | 20—25 дней; при                         |                                          | от света месте                    |
|                                     | превращается в активную  |                                            | неврологических заболеваниях   |                                          |                                            |
|                                     | форму и отличается          |                                             | — по 0,0002—0,0005 г                 |                                          |                                            |
|                                     | большей                            |                                             | ежедневно в течение 10—20       |                                          |                                            |
|                                     | продолжительностью         |                                             | дней                                           |                                          |                                            |
|                                     | действия                           |                                             |                                                    |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Пиридоксина             | Участвует в обмене           | Профилактика и лечение В6  | Для профилактики B6-                 | Могут появляться              | Таблетки по 0,002; 0,005 и |    |
гидрохлорид,             | аминокислот и липидов      | -гиповитаминоза; анемии,     | авитаминоза взрослым внутрь    | аллергические реакции      | 0,01 г ампулы по 1 мл 1%    |
| Pyridoxini                      |                                          | токсикозы беременных,        | по 0,002—0,005 г, детям — по     |                                          | и 5% растворов.                  |
| hydrochloridum              |                                          | паркинсонизм, малая хорея, | 0,002 г в день. С лечебными       |                                          | Хранение: список Б; в         |
| (синоним витамин В6  |                                          | невриты, радикулиты,          | целями взрослым внутрь в          |                                          | защищенном от света        |   |
|                                     |                                          | сахарный диабет,                 | суточной дозе 0,05—0,1 г в 1—2 |                                          | месте                                  |
|                                     |                                          | атеросклероз, заболевания  | приема. Курс лечения 1—2 мес.  |                                          |                                            |
|                                     |                                          | печени и кожи;                     | Внутримышечно вводят по 2 мл  |                                          |                                            |
|                                     |                                          | предупреждение и               | 5% раствора                               |                                          |                                            |
|                                     |                                          | ослабление побочных           |                                                    |                                          |                                            |
|                                     |                                          | эффектов некоторых           |                                                    |                                          |                                            |
|                                     |                                          | противотуберкулезных         |                                                    |                                          |                                            |
|                                     |                                          | препаратов (изониазида и    |                                                    |                                          |                                            |
|                                     |                                          | других) производных            |                                                    |                                          |                                            |
|                                     |                                          | гидразида изоникотиновой   |                                                    |                                          |                                            |
|                                     |                                          | кислоты                               |                                                    |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Ретинола ацетат,      | Обеспечивает                    | Профилактика и лечение      | Внутримышечно и внутрь.           | При передозировке            | Драже и таблетки                |
| Retinoli acetas              | нормальный рост,              | гипо- и авитаминоза А;         | Разовые дозы не должны            | вызывает сонливость,       | ретинола ацетата по 3300  |----|
|                                     | участвует в образовании   | пигментный ретинит,            | превышать 50000 ME для            | вялость, тошноту, рвоту,   | ME и 33000 ME                  |   |
|                                     | зрительных пигментов,      | ксерофтальмия,                   | взрослых и 5000 ME для детей;  | нарушения походки. У        | соответственно; капсулы   |----|
|                                     | регулирующих темновую   | гемералопия; отморожения  | суточные дозы: 100000 ME для   | детей признаками              | по 5000 ME и 33000 ME;      |
|-------------------------------------| адаптацию глаза,               | и ожоги, экзема и другие      | взрослых и 20000 ME для детей  | передозировки могут быть | масляные растворы 3,44% |----|
Ретиволапальмитат, | нормализует обменные      | заболевания кожи;               |                                                    | также повышение              | и 8,6% (для приема             |
| Retinoli palmitas            | процессы                           | комплексная терапия           |                                                    | температуры тела,             | внутрь); масляный               |
| (синоним: витамин А,   |                                          | рахита, инфекционных         |                                                    | кожные сыпи, потливость  | раствор (для                        |
| аксерофтол и др.)        |                                          | болезней, хронических         |                                                    |                                          | внутримышечных               |   |
|                                     |                                          | гастритов, цирроза печени и |                                                    |                                          | инъекций) в ампулах,         |   |
|                                     |                                          | др.                                       |                                                    |                                          | содержащих в 1 мл по         |
|                                     |                                          |                                             |                                                    |                                          | 25000; 50000 или 100000      |
|                                     |                                          |                                             |                                                    |                                          | ME. Драже и таблетки         |
|                                     |                                          |                                             |                                                    |                                          | ретинола пальмитата по      |
|                                     |                                          |                                             |                                                    |                                          | 3300 и 33000 ME;               |   |
|                                     |                                          |                                             |                                                    |                                          | масляные растворы (для     |
|                                     |                                          |                                             |                                                    |                                          | приема внутрь) 1,651%;       |
|                                     |                                          |                                             |                                                    |                                          | 5,5% и 16,5%. Хранение:     |
|                                     |                                          |                                             |                                                    |                                          | список Б; в защищенном     |
|                                     |                                          |                                             |                                                    |                                          | от света месге, при  не    |   |
|                                     |                                          |                                             |                                                    |                                          | выше 10°                             |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Рибофлавин,             | Участвует в регуляции       | Профилактика и лечение      | Внутрь взрослым — по 0,005—   |                                          | Драже и таблетки по            |
| Riboflavinum (синоним:  | окислительно-                   | гипо- и арибофлавиноза;      | 0,01 г 1—3 раза в день (в            |                                          | 0,002 г (для                         |
| витамин В2, флавитол  | восстановительных           | гемералопия,                       | течение 1—11/мес.); детям по   |                                          | профилактических целей); |    |
| и др.)                           | процессов обмена жиров,  | конъюнктивиты, катаракта,   | 0,002—0,005 г (иногда до 0,01 г)  |                                          | таблетки по 0,005—0,01 г   |   |
|                                     | белков и углеводов, а        | язвы роговицы, кератиты;     | в день в зависимости от             |                                          | (для лечебных целей).         |
|                                     | также в поддержании        | длительно незаживающие    | возраста. В глазной практике      |                                          | Хранение: в защищенном    |
|                                     | нормальной зрительной     | раны и язвы, лучевая           | назначают в виде глазных           |                                          | от света месте                    |
|                                     | функции глаза                   | болезнь, спру, вирусный      | капель (0,01% раствор)               |                                          |                                            |
|                                     |                                          | гепатит и др.                        |                                                    |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Рутин, Rutinum            | Обладает свойствами        | Те же, что и у кверцетина    | Внутрь взрослым — по 0,02—     |                                          | Таблетки по 0,02 г.              |
| (синоним: рутозид и     | витамина Р. По свойствам |                                             | 0,05 г 2—3 раза в день                |                                          | Хранение: в сухом,            |   |
| др.)                              | соответствует кверцетину  |                                            |                                                    |                                          | защищенном от света        |   |
|                                     |                                          |                                             |                                                    |                                          | месте                                  |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Тиамина бромид,      | Участвует в процессах      | Профилактика и лечение      | Тиамина бромид взрослым          | Болезненность в месте      | Тиамина хлорид — в           |
| Thiamini bromidum        | углеводного обмена и        | гипо- и авитаминоза В1;        | внутрь по 0,005—0,01 г в день    | введения, аллергические   | таблетках и драже по          |
|                                     | окислительном                  | невриты, невралгии,             | (при необходимости — до 0,05 г  | реакции вплоть до             | 0,002 г; таблетках то          |   |
|                                     | декарбоксилировании        | периферические параличи,                                                     | анафилактического шока   | 0,005 г и 0,01 г, ампулах      |
|                                     | кетокислот, оказывает       | комплексная терапия           | в день). Курс лечения 30—40      |                                          | по 1 мл 2,5% и 5%               |
|                                     | влияние на проведение      | язвенной болезни желудка   | дней. Детям до 1 года по 0,005   |                                          | растворов. Тиамина           |   |
|                                     | нервного возбуждения в    | и двенадцатиперстной         г через день (в течение 40          |                                          | бромид — в таблетках и      |
|                                     | синапсах, обладает           | кишки, атонии кишечника,    | дней); от 1 года до 3 лет —         |                                          | драже по 0,00258 г,             |
|                                     | ганглиоблокирующим         | заболеваний печени;            | сначала по 0,005 г (в течение 24  |                                          | таблетках по 0,00645 и        |
|                                     | действием                         | миокардиодистрофия,          | дней), затем по 0,001 г через      |                                          | 0,0129 г, ампулах по 1 мл  |    |
|                                     |                                          | дерматозы                           | день (в течение 16 дней); от 3     |                                          | 3% и 6% растворов.            |
|-------------------------------------|                                          |                                             | до 8 лет — по 0,015 г через         |                                          | Хранение: в герметически  |---|
| Тиамина хлорид,          |                                          |                                             | день (в течение 20 дней), затем  |                                          | укупоренной таре,               |
| Thiamini chloridum         |                                          |                                             | по 0,03 г (в течение 20 дней), от  |                                          | предохраняющей от            |
| (синоним: витамин В1,  |                                          |                                             | 8 до 16 лет — по 0,03 г в             |                                          | действия света                  |   |
| аневрин и др.)              |                                          |                                             | течение 30 дней, При                  |                                          |                                            |
|                                     |                                          |                                             | назначении тиамина хлорида      |                                          |                                            |
|                                     |                                          |                                             | следует учитывать, что 0,001 г   |                                          |                                            |
|                                     |                                          |                                             | этого препарата соответствует   |                                          |                                            |
|                                     |                                          |                                             | по активности 0,00129 г тиамина |                                          |                                            |
|                                     |                                          |                                             | бромида. Внутримышечно           |                                          |                                            |
|                                     |                                          |                                             | взрослым тиамина хлорид           |                                          |                                            |
|                                     |                                          |                                             | вводят по 1 мл 2,5% или 5%       |                                          |                                            |
|                                     |                                          |                                             | раствора, а тиамина бромид —   |                                          |                                            |
|                                     |                                          |                                             | по 1 мл 3% или 6% раствора       |                                          |                                            |
|                                     |                                          |                                             | ежедневно; детям — по 0,5 мл    |                                          |                                            |
|                                     |                                          |                                             | 2,5% раствора тиамина хлорида  |                                          |                                            |
|                                     |                                          |                                             | или 0,5 мл 3% раствора тиамина |                                          |                                            |
|                                     |                                          |                                             | бромида. Курс лечения — 10—   |                                          |                                            |
|                                     |                                          |                                             | 30 инъекций                                |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|                                     |                                          |                                             |                                                    |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Токоферола ацетат, | Предохраняет различные   | Мышечные дистрофии,        | Внутрь в зависимости от             | При внутримышечном        | 5%, 10% и 30% растворы  |    |
| Tocopheroli acetas        | вещества от окисления.     | нарушения менструального  | характера заболевания               | введении вызывает           | в масле (для приема          |   |
| (синоним: витамин E.   | Участвует в биосинтезе     | цикла, угроза прерывания    | суточные дозы взрослым 0,05—  | болезненность в месте      | внутрь) во флаконах по       |
| α-токоферола ацетат и | гема и белков, а также       | беременности,                     | 0,3 г, детям — по 0,005—0,01r    | введения и образование    | 10, 20, 25 и 50 мл; в           |   |
| др.)                              | пролиферации тканей        | амиотрофический боковой   |                                                    | инфильтратов. Возможны  | капсулах по 0,1 и 0,2 мл      |
|                                     |                                          | склероз, некоторые              |                                                    | аллергические реакции      | 50% раствора. Ампулы по  |   |
|                                     |                                          | заболевания кожи,               |                                                    |                                          | 1 мл 5%, 10% и 30%            |
|                                     |                                          | миокардиодистрофия,          |                                                    |                                          | растворов в масле (для       |
|                                     |                                          | спазмы периферических      |                                                    |                                          | инъекций). Хранение: в        |
|                                     |                                          | сосудов, заболевания          |                                                    |                                          | защищенном от света        |   |
|                                     |                                          | печени и др. В педиатрии     |                                                    |                                          | месте                                  |
|                                     |                                          | препарат применяют при      |                                                    |                                          |                                            |
|                                     |                                          | склеродермии, гипотрофии  |                                                    |                                          |                                            |
|                                     |                                          | и др.                                    |                                                    |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Фосфотиамин,           | По химическому строению | Лечение невритов,               | Внутрь (после еды) взрослым по |                                          | Таблетки по 0,01 и 0,03 г.  |    |
| Phosphothiaminum        | близок к тиамину и            | полиневритов (в т.ч. не        | 0,01 г 3—4 раза в день. При        |                                          | Хранение: в сухом,            |   |
|                                     | обладает основными         | связанных с Ввитаминной  | необходимости разовую дозу      |                                          | защищенном от света        |   |
|                                     | свойствами витамина В   | недостаточностью);             | можно увеличить до 0,03 г. Курс |                                          | месте                                  |
|                                     | но больше депонируется в | астенические состояния,      | лечения — 3—4 нед.                   |                                          |                                            |
|                                     | организме, легче               | комплексная терапия           |                                                    |                                          |                                            |
|                                     | переходит в активную       | недостаточности                  |                                                    |                                          |                                            |
|                                     | форму, менее токсичен     | кровообращения,                 |                                                    |                                          |                                            |
|                                     |                                          | хронических гастритов и      |                                                    |                                          |                                            |
|                                     |                                          | других заболеваний, при      |                                                    |                                          |                                            |
|                                     |                                          | которых показано                 |                                                    |                                          |                                            |
|                                     |                                          | применение тиамина            |                                                    |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Холина хлорид,         | Участвует в обмене           | Комплексная терапия           | Внутрь в виде 20% раствора       | При приеме внутрь может  | Ампулы по 10 мл 20%        |   |
| Cholini chio-ridum          | фосфолипидов,                 | заболеваний печени,            | взрослым по 1 чайной ложке 3— | вызывать диспептические  | раствора                             |
|                                     | предотвращает развитие   | гипертиреоза, цистинурии,   | 5 раз в день. Внутривенно          | расстройства, при             |                                            |
|                                     | жировой инфильтрации      | атеросклероза,                     | (капельно) вводят до 300 мл 1%  | внутривенном введении     |                                            |
|                                     | печени. Является              | хронического алкоголизма и | раствора (со скоростью не          | — тошноту, рвоту,             |                                            |
|                                     | веществом, из которого в  | для повышения                    | более 30 капель в 1 мин).            | ощущение жара,                |                                            |
|                                     | организме образуется        | переносимости некоторых    | Длительность лечения от 7—10   | брадикардию, падение АД |                                            |
|                                     | ацетилхолин                      | лекарственных препаратов   | дней до 3—4 нед. и более           | вплоть до коллапса. В       |                                            |
|                                     |                                          | (кортикостероидов и др.)      |                                                    | связи с этим внутривенно  |                                            |
|                                     |                                          |                                             |                                                    | препарат вводят только     |                                            |
|                                     |                                          |                                             |                                                    | капельно                           |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Цианокобаламин,      | Является фактором роста  | Антианемическое средство, | Внутрь (совместно с кислотой    | При повышенной                | Ампулы по 1 мл 0,003%;      |
| Cyanocobalaminum       | и стимулятором                 | дистрофии у недоношенных | фолиевой) и парентерально        | чувствительности к           | 0,01%; 0,02% и 0,05%        |   |
| (синоним: витамин В12  | гемопоэза, участвует в      | и новорожденных детей,      | (подкожно, внутримышечно,        | препарату могут                | растворов; таблетки,           |
                                    | синтезе различных            | перенесенные инфекции,     | внутривенно). В зависимости от  | возникать аллергические   | содержащие 0,00005 г         |
| и др.)                           | аминокислот, оказывая      | спру, заболевания печени,   | характера и тяжести                   | реакции, тахикардия, боли | цианокобаламина и              |
|                                     | благоприятное влияние на  | полиневриты, радикулиты,   | заболевания разовые дозы для   | в сердце                            | 0,0008 г фолиевой               |
|                                     | функции печени, нервной  | алкогольное отравление,      | взрослых составляют от 30 до    |                                          | кислоты                               |
|                                     | системы, активирует         | детский церебральный         | 500 мкг, т. е. от 1 мл 0,003%       |                                          |                                            |
|                                     | процессы свертывания      | паралич, болезнь Дауна,      | раствора до 1 мл 0,05%              |                                          |                                            |
|                                     | крови, обмен углеводов и  | боковой амиотрофический   | раствора                                     |                                          |                                            |
|                                     | липидов                             | склероз, энцефаломиелит,   |                                                    |                                          |                                            |
|                                     |                                          | заболевания кожи и др.        |                                                    |                                          |                                            |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Эргокальциферол,    | Регулирует обмен кальция | Профилактика и лечение      | Внутрь по 500—1000 ME в день. | При передозировке            | Драже по 500 ME и              |
| Ergocalciferolum            | и фосфора (обеспечивает  | рахита; заболевания            | Длительность применения и        | наблюдаются потеря         | масляный раствор по 500  |    |
| (синоним: витамин D2.  | всасывание кальция и       | костей, обусловленные        | курсовая доза устанавливаются  | аппетита, тошнота,            | и 1000 ME в капсулах          |
| кальциферол и др.)      | фосфора в тонком             | нарушениями обмена           | в соответствии с инструкцией о  | головные боли, слабость,   | (для профилактических       |
|                                     | кишечнике, реабсорбцию   | кальция (остеомаляция и      | профилактике и лечении рахита  | раздражительность,          | целей); масляные                |
|                                     | фосфора в почечных         | некоторые формы                |                                                    | повышение температуры   | растворы 0,0625%;              |
|                                     | канальцах и транспорт       | остеопороза)                        |                                                    | тела, изменения в моче     | 0,125% и 0,5% (для             |
|                                     | кальция из крови в             |                                             |                                                    | (белок, лейкоциты,             | профилактических и            |
|                                     | костную ткань)                  |                                             |                                                    | гиалиновые цилиндры).      | лечебных целей); 0,5%        |
|                                     |                                          |                                             |                                                    | При явлениях                    | спиртовой раствор.            |   |
|                                     |                                          |                                             |                                                    | передозировки препарат    | Хранение: список Б; в         |
|                                     |                                          |                                             |                                                    | отменяют и ограничивают  | защищенном от света        |   |
|                                     |                                          |                                             |                                                    | введение кальция в           | месте                                  |
|                                     |                                          |                                             |                                                    | организм                           |                                            |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Библиогр.: Яковлев Т.Н. Лечебно-профилактическая витаминология, Л., 1981, библиогр.
II Витами́нные сре́дства
лекарственные средства, действующим началом которых являются витамины.

1. Малая медицинская энциклопедия. — М.: Медицинская энциклопедия. 1991—96 гг. 2. Первая медицинская помощь. — М.: Большая Российская Энциклопедия. 1994 г. 3. Энциклопедический словарь медицинских терминов. — М.: Советская энциклопедия. — 1982—1984 гг.

Игры ⚽ Поможем сделать НИР

Полезное


Смотреть что такое "Витаминные средства" в других словарях:

  • витаминные средства — лекарственные средства, действующим началом которых являются витамины …   Большой медицинский словарь

  • ВИТАМИННЫЕ ПРЕПАРАТЫ — лек. средства, содержащие разл. витамины и их сочетания (поливитамины) в определ. соотношениях. В. п. получают гл. обр. синтетически; нек рые изготовляют из растит. (плоды шиповника, облепихи) и животного (печень морских ж ных, кр. рог. скота и… …   Сельско-хозяйственный энциклопедический словарь

  • витаминные препараты — витаминные препараты, лекарственные средства, содержащие различные витамины и их сочетания (поливитамины) в определенных соотношениях. В. п. получают главным образом синтетически; некоторые изготовляют из растительные (плоды шиповника, облепихи)… …   Сельское хозяйство. Большой энциклопедический словарь

  • Витаминные препараты —         лекарственные препараты, содержащие Витамины. В. п. применяют для предупреждения или лечения болезненных состояний, вызванных витаминной недостаточностью (См. Витаминная недостаточность), а также при лечении некоторых других заболеваний.… …   Большая советская энциклопедия

  • Антианемические средства — I Антианемические средства (греч. anti против + Анемии) лекарственные средства, применяемые для лечения анемий. Общепринятой классификации А. с. нет. Среди них условно различают препараты, нормализующие образование эритроцитов и гемоглобина, и… …   Медицинская энциклопедия

  • Противоатеросклеротические средства — I Противоатеросклеротические средства лекарственные средства, предупреждающие развитие атеросклероза. Различают П. с., снижающие в крови содержание атерогенных липопротеинов, и П. с., препятствующие повреждению интимы кровеносных сосудов. К… …   Медицинская энциклопедия

  • Жизненно необходимые и важнейшие лекарственные средства — (ЖНВЛС)  перечень лекарственных средств, утверждаемый Правительством Российской Федерации в целях государственного регулирования цен на лекарственные средства. Перечень ЖНВЛС охватывает практически все виды медицинской помощи,… …   Википедия

  • Лекарственные средства — I Лекарственные средства химические соединения природного или синтетического происхождения и их сочетания, применяемые для лечения, предупреждения и диагностики заболеваний человека и животных. К лекарственным относят также препараты для… …   Медицинская энциклопедия

  • ЛЕКАРСТВЕННЫЕ СРЕДСТВА — в ветеринарии, в ва, используемые для предупреждения, устранения или ослабления болезненного процесса у с. х. ж ных. Применяют также в качестве стимуляторов роста, продуктивности, плодовитости и резистентности организма ж ного. Л. могут оказывать …   Сельско-хозяйственный энциклопедический словарь

  • лекарственные средства — в ветеринарии, вещества, используемые для предупреждения, устранения или ослабления болезненного процесса у сельскохозяйственных животных. Применяют также в качестве стимуляторов роста, продуктивности, плодовитости и резистентности организма… …   Сельское хозяйство. Большой энциклопедический словарь


Поделиться ссылкой на выделенное

Прямая ссылка:
Нажмите правой клавишей мыши и выберите «Копировать ссылку»